• Profile
Close

Combined treatment of primary vitreoretinal lymphomas significantly prolongs the time to first relapse

British Journal of Ophthalmology Feb 03, 2018

Klimova A, et al. - The authors comparatively analyzed the prognosis and survival rate of individuals with vitreoretinal lymphoma with and without central nervous system (CNS) involvement. The relapse of the lymphoma was delayed considerably due to the combined treatment of primary vitreoretinal lymphoma compared to the local therapy alone. A prominent positive prognostic value was obtained through the intraocular involvement when overall survival was compared.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay